RU2015136025A - Устройства для сбора крови, содержащие добавки, ингибирующие контактный путь свертывания крови - Google Patents
Устройства для сбора крови, содержащие добавки, ингибирующие контактный путь свертывания крови Download PDFInfo
- Publication number
- RU2015136025A RU2015136025A RU2015136025A RU2015136025A RU2015136025A RU 2015136025 A RU2015136025 A RU 2015136025A RU 2015136025 A RU2015136025 A RU 2015136025A RU 2015136025 A RU2015136025 A RU 2015136025A RU 2015136025 A RU2015136025 A RU 2015136025A
- Authority
- RU
- Russia
- Prior art keywords
- inhibitor
- factor
- blood
- additive
- kallikrein
- Prior art date
Links
- 239000000654 additive Substances 0.000 title claims 16
- 210000004369 blood Anatomy 0.000 title claims 16
- 239000008280 blood Substances 0.000 title claims 16
- 230000002401 inhibitory effect Effects 0.000 title claims 5
- 230000000996 additive effect Effects 0.000 claims 15
- 101000975003 Homo sapiens Kallistatin Proteins 0.000 claims 13
- 101001077723 Homo sapiens Serine protease inhibitor Kazal-type 6 Proteins 0.000 claims 13
- 229940122920 Kallikrein inhibitor Drugs 0.000 claims 13
- 102100023012 Kallistatin Human genes 0.000 claims 13
- 229940123835 Factor XII inhibitor Drugs 0.000 claims 11
- 239000003112 inhibitor Substances 0.000 claims 11
- 229940105278 Factor XI inhibitor Drugs 0.000 claims 10
- 230000037361 pathway Effects 0.000 claims 10
- 239000000203 mixture Substances 0.000 claims 9
- 238000000034 method Methods 0.000 claims 8
- 108010039627 Aprotinin Proteins 0.000 claims 7
- 229960004405 aprotinin Drugs 0.000 claims 7
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical group C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 claims 7
- 108010074864 Factor XI Proteins 0.000 claims 6
- 108090000190 Thrombin Proteins 0.000 claims 6
- 239000003146 anticoagulant agent Substances 0.000 claims 6
- 229940127219 anticoagulant drug Drugs 0.000 claims 6
- 230000015572 biosynthetic process Effects 0.000 claims 6
- 229960004072 thrombin Drugs 0.000 claims 6
- 230000023555 blood coagulation Effects 0.000 claims 5
- 101001062768 Homo sapiens Coagulation factor XI Proteins 0.000 claims 4
- 239000012503 blood component Substances 0.000 claims 4
- 108010059382 Zea mays trypsin inhibitor Proteins 0.000 claims 3
- 229940122618 Trypsin inhibitor Drugs 0.000 claims 2
- 101710162629 Trypsin inhibitor Proteins 0.000 claims 2
- 240000008042 Zea mays Species 0.000 claims 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims 2
- 235000005822 corn Nutrition 0.000 claims 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical group O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims 2
- 239000001509 sodium citrate Substances 0.000 claims 2
- 230000000087 stabilizing effect Effects 0.000 claims 2
- 239000002753 trypsin inhibitor Substances 0.000 claims 2
- 108010080865 Factor XII Proteins 0.000 claims 1
- 102000000429 Factor XII Human genes 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000015271 coagulation Effects 0.000 claims 1
- 238000005345 coagulation Methods 0.000 claims 1
- 239000000306 component Substances 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 244000052769 pathogen Species 0.000 claims 1
- 210000004623 platelet-rich plasma Anatomy 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/14—Mechanical aspects of preservation; Apparatus or containers therefor
- A01N1/146—Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5021—Test tubes specially adapted for centrifugation purposes
- B01L3/50215—Test tubes specially adapted for centrifugation purposes using a float to separate phases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1406—Septums, pierceable membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/04—Closures and closing means
- B01L2300/041—Connecting closures to device or container
- B01L2300/042—Caps; Plugs
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/04—Closures and closing means
- B01L2300/041—Connecting closures to device or container
- B01L2300/044—Connecting closures to device or container pierceable, e.g. films, membranes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Environmental Sciences (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Dentistry (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Clinical Laboratory Science (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361759742P | 2013-02-01 | 2013-02-01 | |
| US61/759,742 | 2013-02-01 | ||
| PCT/US2014/014089 WO2014121041A1 (en) | 2013-02-01 | 2014-01-31 | Blood collection devices containing contact pathway inhibition additives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2015136025A true RU2015136025A (ru) | 2017-03-06 |
Family
ID=51259520
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015136025A RU2015136025A (ru) | 2013-02-01 | 2014-01-31 | Устройства для сбора крови, содержащие добавки, ингибирующие контактный путь свертывания крови |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20140220552A1 (enExample) |
| EP (1) | EP2950718A4 (enExample) |
| JP (1) | JP2016505159A (enExample) |
| KR (1) | KR20150141940A (enExample) |
| CN (1) | CN105188535A (enExample) |
| AU (1) | AU2014212194A1 (enExample) |
| BR (1) | BR112015018077A2 (enExample) |
| CA (1) | CA2899594A1 (enExample) |
| MX (1) | MX2015009914A (enExample) |
| RU (1) | RU2015136025A (enExample) |
| SG (1) | SG11201505978PA (enExample) |
| WO (1) | WO2014121041A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111044725B (zh) | 2013-01-20 | 2024-03-29 | 武田药品工业株式会社 | 缓激肽介导的病症的评估和治疗 |
| PT3060908T (pt) | 2013-10-21 | 2021-05-27 | Dyax Corp | Diagnóstico e tratamento de doenças autoimunes |
| KR20250066486A (ko) | 2013-10-21 | 2025-05-13 | 다케다 파머수티컬 컴패니 리미티드 | 혈장 칼리크레인 시스템 바이오마커를 결정하기 위한 검정법 |
| JP6758661B2 (ja) * | 2015-05-14 | 2020-09-23 | ゼネラル・エレクトリック・カンパニイ | 血漿の分離および回収のためのキット |
| US10870115B2 (en) * | 2015-08-13 | 2020-12-22 | Dyax Corp. | Evacuated blood collection tubes containing protease inhibitors for the assessment of contact system activation |
| JP6903648B2 (ja) | 2015-10-19 | 2021-07-14 | ダイアックス コーポレーション | 切断高分子量キニノーゲンを検出するイムノアッセイ |
| JP6844890B2 (ja) * | 2016-01-07 | 2021-03-17 | 藤森工業株式会社 | 採血管、試薬及びそれらを利用した血液性状分析方法 |
| CN108342381A (zh) * | 2017-01-24 | 2018-07-31 | 梁建国 | 一种用于稳定保存外周血中循环游离dna的溶剂 |
| US11672733B2 (en) * | 2017-07-21 | 2023-06-13 | Amgen Inc. | Gas permeable sealing member for drug container and methods of assembly |
| US12485412B2 (en) * | 2021-08-05 | 2025-12-02 | Lance Liberti | Kit including biotin for harvesting platelet-rich plasma |
| CN115555070B (zh) * | 2022-10-18 | 2024-11-05 | 北京积水潭医院 | 一种prf离心管 |
| GB202219505D0 (en) * | 2022-12-22 | 2023-02-08 | Turzi Antoine | Medical composition |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002517739A (ja) * | 1998-06-08 | 2002-06-18 | ユニバーシティ オブ バーモント アンド ステイト アグリカルチャー カレッジ | 血液および血液製剤における凝固の抑制 |
| US20030064414A1 (en) * | 2001-03-30 | 2003-04-03 | Benecky Michael J. | Rapid assessment of coagulation activity in whole blood |
| WO2003097237A2 (en) * | 2002-05-13 | 2003-11-27 | Becton, Dickinson, And Company | Protease inhibitor sample collection system |
| CN100556546C (zh) * | 2003-02-13 | 2009-11-04 | 贝克顿·迪金森公司 | 在血液收集过程中去除成分的装置及其使用 |
| WO2005017486A2 (en) * | 2003-06-09 | 2005-02-24 | Mann Kenneth G | A global test of the hemostatic system |
| GB0711779D0 (en) * | 2007-06-18 | 2007-07-25 | Univ Singapore | Thrombin inhibitor |
| AU2008326348B2 (en) * | 2007-11-21 | 2014-01-30 | Oregon Health & Science University | Anti-factor XI monoclonal antibodies and methods of use thereof |
| AU2011336345B2 (en) * | 2010-12-02 | 2016-07-07 | Becton, Dickinson And Company | Blood collection devices containing blood stabilization agent |
| JP6109081B2 (ja) * | 2011-03-09 | 2017-04-05 | ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー | 人工表面との接触を含む医学的手技に伴う投与のためのｆｘｉｉ阻害剤 |
-
2014
- 2014-01-31 US US14/169,290 patent/US20140220552A1/en not_active Abandoned
- 2014-01-31 CA CA2899594A patent/CA2899594A1/en not_active Abandoned
- 2014-01-31 EP EP14746597.5A patent/EP2950718A4/en not_active Withdrawn
- 2014-01-31 BR BR112015018077A patent/BR112015018077A2/pt not_active IP Right Cessation
- 2014-01-31 AU AU2014212194A patent/AU2014212194A1/en not_active Abandoned
- 2014-01-31 SG SG11201505978PA patent/SG11201505978PA/en unknown
- 2014-01-31 CN CN201480019680.XA patent/CN105188535A/zh active Pending
- 2014-01-31 JP JP2015556160A patent/JP2016505159A/ja not_active Withdrawn
- 2014-01-31 RU RU2015136025A patent/RU2015136025A/ru not_active Application Discontinuation
- 2014-01-31 WO PCT/US2014/014089 patent/WO2014121041A1/en not_active Ceased
- 2014-01-31 KR KR1020157023653A patent/KR20150141940A/ko not_active Withdrawn
- 2014-01-31 MX MX2015009914A patent/MX2015009914A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2950718A1 (en) | 2015-12-09 |
| SG11201505978PA (en) | 2015-08-28 |
| CN105188535A (zh) | 2015-12-23 |
| BR112015018077A2 (pt) | 2017-07-18 |
| MX2015009914A (es) | 2015-09-25 |
| AU2014212194A1 (en) | 2015-09-17 |
| CA2899594A1 (en) | 2014-08-07 |
| US20140220552A1 (en) | 2014-08-07 |
| KR20150141940A (ko) | 2015-12-21 |
| WO2014121041A1 (en) | 2014-08-07 |
| JP2016505159A (ja) | 2016-02-18 |
| EP2950718A4 (en) | 2016-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2015136025A (ru) | Устройства для сбора крови, содержащие добавки, ингибирующие контактный путь свертывания крови | |
| JP2016505159A5 (enExample) | ||
| Giannini et al. | Correction of hemostatic abnormalities and portal pressure variations in patients with cirrhosis | |
| EA201992155A1 (ru) | Способы криогенного хранения | |
| EP2547355A4 (en) | TFPI INHIBITORS AND METHODS OF USE THEREOF | |
| RU2012139181A (ru) | Стабильная композиция, содержащая антитело | |
| ATE499882T1 (de) | Gefässwundverschluss-vorrichtung | |
| EA201590169A1 (ru) | Устройство в виде сухого карандаша и способ определения анализируемого вещества в образце | |
| PE20141264A1 (es) | Procedimiento de obtencion de una composicion que contiene factores de crecimiento a partir de un compuesto sanguineo, y composicion obtenible por dicho procedimiento | |
| BR112014017226B1 (pt) | Método para estabilizar ácidos graxos e método de preparação de um meio sólido | |
| WO2020023906A3 (en) | Polymer-based biospecimen collection devices and uses thereof | |
| ES2571127T3 (es) | Método para la separación de moléculas o partículas objetivo a partir de muestras que contienen fibrinógeno, incluyendo componentes sanguíneos | |
| Yokoyama et al. | Risk factors for transfusion after orthotopic liver transplantation | |
| WO2018087367A3 (en) | Tissue collection device for collection of one or more tissue samples from a biopsy needle or biopsy device and biopsy device comprising such a tissue collection device | |
| Dentali et al. | Recurrent venous thromboembolism: a role for ABO blood group? | |
| RU2016102202A (ru) | Биологический маркер опухоли | |
| WO2014176167A3 (en) | Drug concentration from an oral fluid | |
| MX2022007465A (es) | Metodos y composiciones para evaluar y tratar fibrosis. | |
| Lee et al. | Serum osteopontin level correlates with carotid-femoral pulse wave velocity in kidney transplantation patients | |
| Contreras-López et al. | Oral anticoagulant therapy in cirrhotic patients and two cases of liver transplantation: 6AP3-6 | |
| Contreras et al. | The important role of fibrinogen in bleeding during brain meningioma resection: 6AP3-5 | |
| MY170270A (en) | Method to extract leech hirudin | |
| 陳志魁 et al. | Bleeding after Surgical or Non-Surgical Dental Extraction in Patients with Abnormal Platelet Function on PFA-100 Test-A Retrospective Cohort Study | |
| Ignatavičius | Clinical importance of extent and location of pancreatic necrosis in acute pancreatitis | |
| Khanam et al. | Chemokine ligand CXCL-8 mediated activation and neutrophil influx aggravates liver injury and correlates with clinical severity indices in acute-on-chronic liver failure (ACLF): 283 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20180321 |